
Nevro Corp. NVRO
Annual report 2024
added 03-04-2025
Nevro Corp. EV/EBITDA Ratio 2011-2026 | NVRO
Annual EV/EBITDA Ratio Nevro Corp.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -23.6 | -101 | -48.4 | -41.4 | -90.9 | -118 | -25.5 | -6.97 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -6.97 | -118 | -57 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
-1.06 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
1.65 | - | - | $ 3.31 B | ||
|
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M | ||
|
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
-14.6 | $ 11.7 | 4.46 % | $ 331 M | ||
|
Apollo Endosurgery
APEN
|
-14 | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
-8.6 | $ 8.23 | -0.12 % | $ 1.24 B | ||
|
Aziyo Biologics
AZYO
|
0.0693 | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
-4.19 | $ 4.33 | 1.88 % | $ 162 M | ||
|
BioSig Technologies
BSGM
|
-0.502 | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
-0.0908 | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
20.1 | $ 73.64 | -0.09 % | $ 4.02 B | ||
|
LENSAR
LNSR
|
-6.76 | $ 5.95 | 1.19 % | $ 71.2 M | ||
|
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
-16.5 | $ 2.36 | 2.16 % | $ 52 M | ||
|
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | ||
|
Cytosorbents Corporation
CTSO
|
-4.95 | $ 0.46 | -2.09 % | $ 28.6 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-165 | $ 18.43 | -0.38 % | $ 432 M | ||
|
Delcath Systems
DCTH
|
329 | $ 11.45 | 1.96 % | $ 410 M | ||
|
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-20.6 | - | - | $ 111 M | ||
|
Profound Medical Corp.
PROF
|
-2.87 | $ 6.97 | 0.72 % | $ 211 M | ||
|
IRIDEX Corporation
IRIX
|
-17 | $ 1.01 | 1.0 % | $ 17.1 M | ||
|
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-1.15 | - | - | $ 10.2 M | ||
|
MiMedx Group
MDXG
|
-669 | $ 3.61 | -4.75 % | $ 534 M | ||
|
Pulmonx Corporation
LUNG
|
-22.5 | $ 1.54 | - | $ 62.7 M | ||
|
Electromed
ELMD
|
15.9 | $ 38.58 | 2.23 % | $ 326 M | ||
|
Myomo
MYO
|
-3.47 | $ 0.95 | 3.85 % | $ 39.8 M | ||
|
Butterfly Network
BFLY
|
-11.2 | $ 4.48 | 2.05 % | $ 1.11 B | ||
|
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
-0.274 | - | -0.97 % | $ 54.4 M | ||
|
Sintx Technologies
SINT
|
-0.898 | $ 2.3 | 5.99 % | $ 6.38 M | ||
|
Orthofix Medical
OFIX
|
31.1 | $ 10.41 | -14.32 % | $ 412 M | ||
|
GBS
GBS
|
-0.713 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
16.8 | $ 84.61 | 0.69 % | $ 11.4 B | ||
|
Insulet Corporation
PODD
|
33.9 | $ 156.89 | 0.19 % | $ 11 B | ||
|
TransMedics Group
TMDX
|
-12.1 | $ 68.85 | 1.25 % | $ 2.34 B | ||
|
CONMED Corporation
CNMD
|
40.2 | $ 37.02 | 0.03 % | $ 1.15 B | ||
|
Inspire Medical Systems
INSP
|
-152 | $ 44.74 | 1.36 % | $ 1.31 B | ||
|
Integer Holdings Corporation
ITGR
|
18.2 | $ 90.0 | -1.63 % | $ 3.13 B | ||
|
Invacare Corporation
IVC
|
0.534 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
34.7 | $ 83.2 | 0.28 % | $ 48.7 B |